AOBiome Revenue and Competitors
Estimated Revenue & Valuation
- AOBiome's estimated annual revenue is currently $2.8M per year.
- AOBiome's estimated revenue per employee is $155,000
Employee Data
- AOBiome has 18 Employees.
- AOBiome grew their employee count by 6% last year.
AOBiome's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO and SVP Manufacturing | Reveal Email/Phone |
2 | VP, Manufacturing Operations & Quality | Reveal Email/Phone |
3 | SVP Strategic Alliances and Communications | Reveal Email/Phone |
4 | VP Research & Development | Reveal Email/Phone |
5 | Senior Director, Research & Development | Reveal Email/Phone |
6 | Chief Staff & Director Program Management | Reveal Email/Phone |
7 | Director, Manufacturing and Supply Chain | Reveal Email/Phone |
8 | President and CEO | Reveal Email/Phone |
9 | Inventor and Founder | Reveal Email/Phone |
AOBiome Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is AOBiome?
AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study to treat patients with adult eczema (atopic dermatitis), a Phase 2 study for the prevention of episodic migraines, and a Phase 1b/2a clinical trial for the treatment of allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AOBiome News
AOBiome Therapeutics, a clinical stage biotechnology company focused on transforming human health by developing topical biologic therapies for...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.1M | 18 | -10% | $161M |
#2 | $3.5M | 18 | N/A | N/A |
#3 | $1.6M | 18 | N/A | N/A |
#4 | $2.5M | 18 | -14% | N/A |
#5 | $3.5M | 18 | -40% | N/A |